Responses
Clinical and epidemiological research
Extended report
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study
Compose a Response to This Article
Other responses
No responses have been published for this article.